A Study of Genetic Variation Influencing Pain and Response to Opioid Medications
Trial ID or NCT#
Status
Purpose
The investigators will be collecting saliva DNA samples from chronic back pain patients. The investigators hope to find candidate genes associated with response to opioid medication by correlating molecular genetics data with pain measurement and opioid responsiveness data including opioid hyperalgesia and opioid analgesic tolerance.
Official Title
A Study of Genetic Variation Influencing Pain and Response to Opioid Medications in Patients With Chronic Pain
Eligibility Criteria
- 1. Adult patient, aged 18-71 2. Recipient of chronic opioid therapy 3. Patient is able to produce a saliva sample 4. If a past study participant, patient will have agreed to be contacted for future studies.
- a. not meeting inclusion criteria
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Dan Hoang
6508874677
View on ClinicalTrials.gov